Hepatitis C

Hepatitis C is an inflammation of the liver caused by a virus. It was discovered about twenty-eight years ago. The liver is very essential to life because it has many important functions in our bodies. Hepatitis C is a blood-borne virus. Hepatitis C is not a virus that you can visibly see unless you run a blood test and discover it in the blood. Hepatitis C is contagious but it is treatable and is considered cured if the virus is no longer detectable in your blood. Considering that some of the Hepatitis

Hepatitis C is a form of liver inflammation caused by the hepacivirus, a member of the Flaviviridae family.It is a highly infectious blood born disease most commonly transmitted by shared needles among drug users. According to the CDC it affects approximately 3.9 million Americans and unfortunately 2.7 million of those individuals are chronically infected. Because the signs and symptoms may not appear sometimes for up to 20-30 years, many people may die from the chronic illness as the disease has

Hepatitis C is a liver disease that is spread from one person to another by the contact of uninfected blood with that of someone who is infected. After having the disease for a number of years, someone who is infected with Hepatitis C is likely to have liver problems in the future, which could lead to cirrhosis and liver cancer within twenty years of being infected. Over the years, many infectious disease specialists have found treatments that manage the disease, but, in 2013, Gilead Sciences created

Hepatitis C : The Silent Epidemic Introduction      Did you know that over two hundred million people are infected with the Hepatitis C Virus (HCV)? Unfortunately it is true, and twenty five thousand more are infected each year. Out of these victims, three are acquaintances of mine. They are why I chose to research this Silent Epidemic. In this paper you will not only learn about the virus itself, but also ways to recognize and prevent it. The goal of this is to prevent the further spread of

Hepatitis C Research Paper Laura A. Symicek October 17, 2014   Hepatitis C Research Paper This research paper is going to review today’s silent killer, the Hepatitis C virus. This paper will talk about the description of the disease, the signs and symptoms, the etiology and risk factors, diagnostic studies, treatments and prognosis of this disease. I had lived with this disease for over ten years before diagnosed so it is important to understand the signs and symptoms so the disease can be identified

Hepatitis C is definitely not a public health crisis that needs emergency intervention in terms of the policy makers being pressured to make a decision urgently. However, thousands of citizens of the United States die on a yearly basis from this contagious disease (CDC, 2014). This makes it a serious public health issue. Hepatitis C is basically a liver disease that is contagious in nature and could be fatal if left untreated. According to the CDC website over 3 million Americans are infected with

Chronic hepatitis C is a leading cause of advanced liver disease and hepatocellular carcinoma in Egypt. The current standard of care of HCV which includes DAAs had achieved a remarkable increase in the SVR rates approaching 95% and had led to improvement in the prognosis of HCV-induced liver disease with a reduction in the associated morbidity and mortality. The occurence of OCI in patients with positive anti HCV antibodies and negative HCV-RNA is unknown and not investigated. The detection of HCV-RNA

Our study included hundred treatment naïve Egyptian patients with chronic hepatitis C mono infection (67%, males and 33% females); their mean age (± SD) was 40.29 years (± 10.98). Significant fibrosis (≥ F2) was present in 62 patients, advanced fibrosis (≥ F3) was present in 24 patients and cirrhosis (F4) was present in 11 patients, other general characteristics of the study population are summarized in table 1. The mean values ± SD of Hepa-Index parameters were: Platelets count (201.58 ± 59.02 109/L)

Hepatitis C is a significant public health problem in Australia with approximately 10000 new infections occurring annually1. In 25% of patients, acute Hepatitis C infection is followed by viral clearance, defined as undetectable levels of HCV RNA in the blood, with the remaining 75% progressing to chronic infection. Without intervention, those with chronic infection are at increased risk of hepatic fibrosis and progression to hepatic cirrhosis. There appears to be a significant variation in the reported

What is Hepatitis C? Hepatitis C virus (HCV) infection causes chronic liver. Over time, infections can lead to liver damage, liver cancer, and even liver failure. HCV is a blood-borne virus. This means that it spreads to a person through contact with the infected blood to another person. The most common method is promoting HCV using contaminated needles and other equipment for use in the field of medicine. Sharing can come into contact with the blood in private items such as razors or toothbrushes